- •Contents
- •Contributors
- •1 Introduction
- •2.1 Posterior Compartment
- •2.2 Anterior Compartment
- •2.3 Middle Compartment
- •2.4 Perineal Body
- •3 Compartments
- •3.1 Posterior Compartment
- •3.1.1 Connective Tissue Structures
- •3.1.2 Muscles
- •3.1.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2 Anterior Compartment
- •3.2.1 Connective Tissue Structures
- •3.2.2 Muscles
- •3.2.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2.4 Important Vessels, Nerves, and Lymphatics of the Anterior Compartment
- •3.3 Middle Compartment
- •3.3.1 Connective Tissue Structures
- •3.3.2 Muscles
- •3.3.3 Reinterpreted Anatomy and Clinical Relevance
- •3.3.4 Important Vessels, Nerves, and Lymphatics of the Middle Compartment
- •4 Perineal Body
- •References
- •MR and CT Techniques
- •1 Introduction
- •2.1 Introduction
- •2.2.1 Spasmolytic Medication
- •2.3.2 Diffusion-Weighted Imaging
- •2.3.3 Dynamic Contrast Enhancement
- •3 CT Technique
- •3.1 Introduction
- •3.2 Technical Disadvantages
- •3.4 Oral and Rectal Contrast
- •References
- •Uterus: Normal Findings
- •1 Introduction
- •References
- •1 Clinical Background
- •1.1 Epidemiology
- •1.2 Clinical Presentation
- •1.3 Embryology
- •1.4 Pathology
- •2 Imaging
- •2.1 Technique
- •2.2.1 Class I Anomalies: Dysgenesis
- •2.2.2 Class II Anomalies: Unicornuate Uterus
- •2.2.3 Class III Anomalies: Uterus Didelphys
- •2.2.4 Class IV Anomalies: Bicornuate Uterus
- •2.2.5 Class V Anomalies: Septate Uterus
- •2.2.6 Class VI Anomalies: Arcuate Uterus
- •2.2.7 Class VII Anomalies
- •References
- •Benign Uterine Lesions
- •1 Background
- •1.1 Uterine Leiomyomas
- •1.1.1 Epidemiology
- •1.1.2 Pathogenesis
- •1.1.3 Histopathology
- •1.1.4 Clinical Presentation
- •1.1.5 Therapy
- •1.1.5.1 Indications
- •1.1.5.2 Medical Therapy and Ablation
- •1.1.5.3 Surgical Therapy
- •1.1.5.4 Uterine Artery Embolization (UAE)
- •1.1.5.5 Magnetic Resonance-Guided Focused Ultrasound
- •2 Adenomyosis of the Uterus
- •2.1 Epidemiology
- •2.2 Pathogenesis
- •2.3 Histopathology
- •2.4 Clinical Presentation
- •2.5 Therapy
- •3 Imaging
- •3.2 Magnetic Resonance Imaging
- •3.2.1 Magnetic Resonance Imaging: Technique
- •3.2.2 MR Appearance of Uterine Leiomyomas
- •3.2.3 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.4 Histologic Subtypes and Forms of Degeneration
- •3.2.5 Differential Diagnosis
- •3.2.6 MR Appearance of Uterine Adenomyosis
- •3.2.7 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.8 Differential Diagnosis
- •3.3 Computed Tomography
- •3.3.1 CT Technique
- •3.3.2 CT Appearance of Uterine Leiomyoma and Adenomyosis
- •3.3.3 Atypical Appearances on CT and Differential Diagnosis
- •4.1 Indications
- •4.2 Technique
- •Bibliography
- •Cervical Cancer
- •1 Background
- •1.1 Epidemiology
- •1.2 Pathogenesis
- •1.3 Screening
- •1.4 HPV Vaccination
- •1.5 Clinical Presentation
- •1.6 Histopathology
- •1.7 Staging
- •1.8 Growth Patterns
- •1.9 Treatment
- •1.9.1 Treatment of Microinvasive Cervical Cancer
- •1.9.2 Treatment of Grossly Invasive Cervical Carcinoma (FIGO IB-IVA)
- •1.9.3 Treatment of Recurrent Disease
- •1.9.4 Treatment of Cervical Cancer During Pregnancy
- •1.10 Prognosis
- •2 Imaging
- •2.1 Indications
- •2.1.1 Role of CT and MRI
- •2.2 Imaging Technique
- •2.2.2 Dynamic MRI
- •2.2.3 Coil Technique
- •2.2.4 Vaginal Opacification
- •2.3 Staging
- •2.3.1 General MR Appearance
- •2.3.2 Rare Histologic Types
- •2.3.3 Tumor Size
- •2.3.4 Local Staging
- •2.3.4.1 Stage IA
- •2.3.4.2 Stage IB
- •2.3.4.3 Stage IIA
- •2.3.4.4 Stage IIB
- •2.3.4.5 Stage IIIA
- •2.3.4.6 Stage IIIB
- •2.3.4.7 Stage IVA
- •2.3.4.8 Stage IVB
- •2.3.5 Lymph Node Staging
- •2.3.6 Distant Metastases
- •2.4 Specific Diagnostic Queries
- •2.4.1 Preoperative Imaging
- •2.4.2 Imaging Before Radiotherapy
- •2.5 Follow-Up
- •2.5.1 Findings After Surgery
- •2.5.2 Findings After Chemotherapy
- •2.5.3 Findings After Radiotherapy
- •2.5.4 Recurrent Cervical Cancer
- •2.6.1 Ultrasound
- •2.7.1 Metastasis
- •2.7.2 Malignant Melanoma
- •2.7.3 Lymphoma
- •2.8 Benign Lesions of the Cervix
- •2.8.1 Nabothian Cyst
- •2.8.2 Leiomyoma
- •2.8.3 Polyps
- •2.8.4 Rare Benign Tumors
- •2.8.5 Cervicitis
- •2.8.6 Endometriosis
- •2.8.7 Ectopic Cervical Pregnancy
- •References
- •Endometrial Cancer
- •1.1 Epidemiology
- •1.2 Pathology and Risk Factors
- •1.3 Symptoms and Diagnosis
- •2 Endometrial Cancer Staging
- •2.1 MR Protocol for Staging Endometrial Carcinoma
- •2.2.1 Stage I Disease
- •2.2.2 Stage II Disease
- •2.2.3 Stage III Disease
- •2.2.4 Stage IV Disease
- •4 Therapeutic Approaches
- •4.1 Surgery
- •4.2 Adjuvant Treatment
- •4.3 Fertility-Sparing Treatment
- •5.1 Treatment of Recurrence
- •6 Prognosis
- •References
- •Uterine Sarcomas
- •1 Epidemiology
- •2 Pathology
- •2.1 Smooth Muscle Tumours
- •2.2 Endometrial Stromal Tumours
- •3 Clinical Background
- •4 Staging
- •5 Imaging
- •5.1 Leiomyosarcoma
- •5.2.3 Undifferentiated Uterine Sarcoma
- •5.3 Adenosarcoma
- •6 Prognosis and Treatment
- •References
- •1.1 Anatomical Relationships
- •1.4 Pelvic Fluid
- •2 Developmental Anomalies
- •2.1 Congenital Abnormalities
- •2.2 Ovarian Maldescent
- •3 Ovarian Transposition
- •References
- •1 Introduction
- •4 Benign Adnexal Lesions
- •4.1.1 Physiological Ovarian Cysts: Follicular and Corpus Luteum Cysts
- •4.1.1.1 Imaging Findings in Physiological Ovarian Cysts
- •4.1.1.2 Differential Diagnosis
- •4.1.2 Paraovarian Cysts
- •4.1.2.1 Imaging Findings
- •4.1.2.2 Differential Diagnosis
- •4.1.3 Peritoneal Inclusion Cysts
- •4.1.3.1 Imaging Findings
- •4.1.3.2 Differential Diagnosis
- •4.1.4 Theca Lutein Cysts
- •4.1.4.1 Imaging Findings
- •4.1.4.2 Differential Diagnosis
- •4.1.5 Polycystic Ovary Syndrome
- •4.1.5.1 Imaging Findings
- •4.1.5.2 Differential Diagnosis
- •4.2.1 Cystadenoma
- •4.2.1.1 Imaging Findings
- •4.2.1.2 Differential Diagnosis
- •4.2.2 Cystadenofibroma
- •4.2.2.1 Imaging Features
- •4.2.3 Mature Teratoma
- •4.2.3.1 Mature Cystic Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •4.2.3.2 Monodermal Teratoma
- •Imaging Findings
- •4.2.4 Benign Sex Cord-Stromal Tumors
- •4.2.4.1 Fibroma and Thecoma
- •Imaging Findings
- •4.2.4.2 Sclerosing Stromal Tumor
- •Imaging Findings
- •4.2.5 Brenner Tumors
- •4.2.5.1 Imaging Findings
- •4.2.5.2 Differential Diagnosis
- •5 Functioning Ovarian Tumors
- •References
- •1 Introduction
- •2.1 Context
- •2.2.2 Indications According to Simple Rules
- •References
- •CT and MRI in Ovarian Carcinoma
- •1 Introduction
- •2.1 Familial or Hereditary Ovarian Cancers
- •3 Screening for Ovarian Cancer
- •5 Tumor Markers
- •6 Clinical Presentation
- •7 Imaging of Ovarian Cancer
- •7.1.2 Peritoneal Carcinomatosis
- •7.1.3 Ascites
- •7.3 Staging of Ovarian Cancer
- •7.3.1 Staging by CT and MRI
- •Imaging Findings According to Tumor Stages
- •Value of Imaging
- •7.3.2 Prediction of Resectability
- •7.4 Tumor Types
- •7.4.1 Epithelial Ovarian Cancer
- •High-Grade Serous Ovarian Cancer
- •Low-Grade Serous Ovarian Cancer
- •Mucinous Epithelial Ovarian Cancer
- •Endometrioid Ovarian Carcinomas
- •Clear Cell Carcinomas
- •Imaging Findings of Epithelial Ovarian Cancers
- •Differential Diagnosis
- •Borderline Tumors
- •Imaging Findings
- •Differential Diagnosis
- •Recurrent Ovarian Cancer
- •Imaging Findings
- •Differential Diagnosis
- •Value of Imaging
- •Malignant Germ Cell Tumors
- •Dysgerminomas
- •Imaging Findings
- •Differential Diagnosis
- •Immature Teratomas
- •Imaging Findings
- •Malignant Transformation in Benign Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •Sex-Cord Stromal Tumors
- •Granulosa Cell Tumors
- •Imaging Findings
- •Sertoli-Leydig Cell Tumor
- •Imaging Findings
- •Ovarian Lymphoma
- •Imaging Findings
- •Differential Diagnosis
- •7.4.3 Ovarian Metastases
- •Imaging Findings
- •Differential Diagnosis
- •7.5 Fallopian Tube Cancer
- •7.5.1 Imaging Findings
- •Differential Diagnosis
- •References
- •Endometriosis
- •1 Introduction
- •2.1 Sonography
- •3 MR Imaging Findings
- •References
- •Vagina and Vulva
- •1 Introduction
- •3.1 CT Appearance
- •3.2 MRI Protocol
- •3.3 MRI Appearance
- •4.1 Imperforate Hymen
- •4.2 Congenital Vaginal Septa
- •4.3 Vaginal Agenesis
- •5.1 Vaginal Cysts
- •5.1.1 Gardner Duct Cyst (Mesonephric Cyst)
- •5.1.2 Bartholin Gland Cyst
- •5.2.1 Vaginal Infections
- •5.2.1.1 Vulvar Infections
- •5.2.1.2 Vulvar Thrombophlebitis
- •5.3 Vulvar Trauma
- •5.4 Vaginal Fistula
- •5.5 Post-Radiation Changes
- •5.6 Benign Tumors
- •6.1 Vaginal Malignancies
- •6.1.1 Primary Vaginal Carcinoma
- •6.1.1.1 MRI Findings
- •6.1.1.2 Lymph Node Drainage
- •6.1.1.3 Recurrence and Complications
- •6.1.2 Non-squamous Cell Carcinomas of the Vagina
- •6.1.2.1 Adenocarcinoma
- •6.1.2.2 Melanoma
- •6.1.2.3 Sarcomas
- •6.1.2.4 Lymphoma
- •6.2 Vulvar Malignancies
- •6.2.1 Vulvar Carcinoma
- •6.2.2 Melanoma
- •6.2.3 Lymphoma
- •6.2.4 Aggressive Angiomyxoma of the Vulva
- •7 Vaginal Cuff Disease
- •7.1 MRI Findings
- •8 Foreign Bodies
- •References
- •Imaging of Lymph Nodes
- •1 Background
- •3 Technique
- •3.1.1 Intravenous Unspecific Contrast Agents
- •3.1.2 Intravenous Tissue-Specific Contrast Agents
- •References
- •1 Introduction
- •2.1.1 Imaging Findings
- •2.1.2 Differential Diagnosis
- •2.1.3 Value of Imaging
- •2.2 Pelvic Inflammatory
- •2.2.1 Imaging Findings
- •2.3 Hydropyosalpinx
- •2.3.1 Imaging Findings
- •2.3.2 Differential Diagnosis
- •2.4 Tubo-ovarian Abscess
- •2.4.1 Imaging Findings
- •2.4.2 Differential Diagnosis
- •2.4.3 Value of Imaging
- •2.5 Ovarian Torsion
- •2.5.1 Imaging Findings
- •2.5.2 Differential Diagnosis
- •2.5.3 Diagnostic Value
- •2.6 Ectopic Pregnancy
- •2.6.1 Imaging Findings
- •2.6.2 Differential Diagnosis
- •2.6.3 Value of Imaging
- •3.1 Pelvic Congestion Syndrome
- •3.1.1 Imaging Findings
- •3.1.2 Differential Diagnosis
- •3.1.3 Value of Imaging
- •3.2 Ovarian Vein Thrombosis
- •3.2.1 Imaging Findings
- •3.2.2 Differential Diagnosis
- •3.2.3 Value of Imaging
- •3.3 Appendicitis
- •3.3.1 Imaging Findings
- •3.3.2 Value of Imaging
- •3.4 Diverticulitis
- •3.4.1 Imaging Findings
- •3.4.2 Differential Diagnosis
- •3.4.3 Value of Imaging
- •3.5 Epiploic Appendagitis
- •3.5.1 Imaging Findings
- •3.5.2 Differential Diagnosis
- •3.5.3 Value of Imaging
- •3.6 Crohn’s Disease
- •3.6.1 Imaging Findings
- •3.6.2 Differential Diagnosis
- •3.6.3 Value of Imaging
- •3.7 Rectus Sheath Hematoma
- •3.7.1 Imaging Findings
- •3.7.2 Differential Diagnosis
- •3.7.3 Value of Imaging
- •References
- •MRI of the Pelvic Floor
- •1 Introduction
- •2 Imaging Techniques
- •3.1 Indications
- •3.2 Patient Preparation
- •3.3 Patient Instruction
- •3.4 Patient Positioning
- •3.5 Organ Opacification
- •3.6 Sequence Protocols
- •4 MR Image Analysis
- •4.1 Bony Pelvis
- •5 Typical Findings
- •5.1 Anterior Compartment
- •5.2 Middle Compartment
- •5.3 Posterior Compartment
- •5.4 Levator Ani Muscle
- •References
- •Evaluation of Infertility
- •1 Introduction
- •2 Imaging Techniques
- •2.1 Hysterosalpingography
- •2.1.1 Cycle Considerations
- •2.1.2 Technical Considerations
- •2.1.3 Side Effects and Complications
- •2.1.5 Pathological Findings
- •2.1.6 Limitations of HSG
- •2.2.1 Cycle Considerations
- •2.2.2 Technical Considerations
- •2.2.2.1 Normal and Abnormal Anatomy
- •2.2.3 Accuracy
- •2.2.4 Side Effects and Complications
- •2.2.5 Limitations of Sono-HSG
- •2.3 Magnetic Resonance Imaging
- •2.3.1 Indications
- •2.3.2 Technical Considerations
- •2.3.3 Limitations
- •3 Ovulatory Dysfunction
- •4 Pituitary Adenoma
- •5 Polycystic Ovarian Syndrome
- •7 Uterine Disorders
- •7.1 Müllerian Duct Anomalies
- •7.1.1 Class I: Hypoplasia or Agenesis
- •7.1.2 Class II: Unicornuate
- •7.1.3 Class III: Didelphys
- •7.1.4 Class IV: Bicornuate
- •7.1.5 Class V: Septate
- •7.1.6 Class VI: Arcuate
- •7.1.7 Class VII: Diethylstilbestrol Related
- •7.2 Adenomyosis
- •7.3 Leiomyoma
- •7.4 Endometriosis
- •References
- •MR Pelvimetry
- •1 Clinical Background
- •1.3.1 Diagnosis
- •1.3.2.1 Cephalopelvic Disproportion
- •1.3.4 Inadequate Progression of Labor due to Inefficient Contraction (“the Powers”)
- •2.2 Palpation of the Pelvis
- •3 MR Pelvimetry
- •3.2 MR Imaging Protocol
- •3.3 Image Analysis
- •3.4 Reference Values for MR Pelvimetry
- •5 Indications for Pelvimetry
- •References
- •MR Imaging of the Placenta
- •2 Imaging of the Placenta
- •3 MRI Protocol
- •4 Normal Appearance
- •4.1 Placenta Variants
- •5 Placenta Adhesive Disorders
- •6 Placenta Abruption
- •7 Solid Placental Masses
- •9 Future Directions
- •References
- •Erratum to: Endometrial Cancer
CT and MRI in Ovarian Carcinoma |
319 |
|
|
Fig. 30 Metastases from colon cancer. Sagittal CT shows a well-delineated mixed cystic and solid ovarian mass (arrow), which abuts the uterus fundus and elevates small- bowel loops. No ascites was found in the pelvis or abdomen. In this patient with stage T4 colon cancer, differentiation of metastasis from ovarian cancer is not possible by imaging
However, the tubal origin has been proven for most high serous ovarian cancers as well as for most of the hereditary ovarian cancers. Based on these new insights, the FIGO 2014 staging classification has unified ovarian, fallopian tube, and peritoneal cancer in its staging classification.
7.5.1\ Imaging Findings
A unilateral adnexal complex cystic or solid mass associated with hydrosalpinx is the most common finding (Kawakami et al. 1993; Gomes et al. 2015). CT and MRI demonstrate complex solid and cystic enhancing masses similar to ovarian cancer. A cystic tubular structure with interdigitating septa adjacent to the mass represents the dilated tube. Signal intensity on T1 and T2 higher than serous fluid suggests hematosalpinx. Occasionally, focal nodular-
ity within a hydrosalpinx may be found in fallopian cancer. Common associated findings are distension of the uterine cavity and ascites (Gomes et al. 2015). Peritoneal metastases are similar to those in ovarian cancer. Lymph node metastases may be found more often than in ovarian cancer (Gomes et al. 2015).
Differential Diagnosis
A solid mass arising within the dilated fallopian tube or a sausage-like adnexal mass has been described as a feature characterizing fallopian tubal cancer (Gomes et al. 2015). Especially with T2-weighted images, identification of the cystic components of the distended tube may be possible. Metastases to the fallopian tubes, which result most commonly from direct extension of gynecologic cancers, cannot be reliably differentiated from primary fallopian tube cancers. Rarely, leiomyomas of the fallopian tube may be encountered, which resemble ovarian stromal tumors or fibroids of the broad ligament.
References
Akin O, Sala E, Chaya S et al (2008) Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology 248:511–517
Alcazar JL, Galan MJ, Ceamanos C et al (2003) Transvaginal gray scale and color Doppler sonography in primary ovarian cancer and metastatic tumors to the ovary. J Ultrasound Med 22:243–247
AlvarezRM,Vazquez-VicenteD(2015)Fertilitysparingtreat- mentinborderlineovariantumors.Ecancermedicalscience 9:507. doi:10.3332/ecancer.2015.507
Anthuber C, Engel J, Mayr D, Petrides P (2014) Keimstrangstromatumoren.www.journalonko.de6:418–420 Bachmann C, Bachmann R, Kraemer B, Brucker SY et al (2016) Prevalence and distribution pattern of nodal metastases in advanced ovarian cancer. Mol Clin
Oncol 5:483–487
Bairey O, Blickstein D, Stark P et al (2003) Serum CA 125 as a prognostic factor in non-Hodgkin’s lymphoma. Leuk Lymphoma 44:1733–1738
Bazot M, Cortez A, Sananes S, Boudghene F et al (1999) Imaging of dermoid cysts with foci of immature tissue. J Comput Assist Tomogr 23:703–706
Bent CL, Sahdev A, Rockall A, Singh N, Sohaib A, Reznek RH (2009) MRI appearance of borderline ovarian tumors. Clin Radiol 64:430–438
320 |
R. Forstner |
|
|
Bernardin L, Dilks P, Liyanage S, Miquel ME, Sahdev A, Rockall A (2012) Effectiveness of semi-quantita- tive multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation. Eur Radiol 22:880–890
Bigorie V, Morice P, Pierre D, Antoine M et al (2010) Ovarian metastases from breast cancer: report of 29 cases. Cancer 116:799–804
Birrer MJ (2016) Medical treatment for relapsed ovarian fallopian tubal, or peritoneal cancer: platinum- resistant disease.www.uptodate.com
Borley J, Wilhelm-Benartzi C, Williamson R, Bharwani N et al (2015) Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer. BJOG 122:843–849
Bristow RE, Duska LR, Lambrou NC et al (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540
Brown DL, Zou KH, Tempany CM et al (2001) Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the radiology diagnostic oncology group study. Radiology 219:213–218
Burghardt E (1993) Epithelial ovarian cancer. Recurrence. In: Burghardt E (ed) Surgical gynecological oncology. Thieme, Stuttgart, p 494
Buy JN, Ghossain MA, Sciot C et al (1991) Epithelial tumors of the ovary: CT findings and correlation with US. Radiology 178:811–818
Buys SS, Partrige EP, Black A, Johnson CC et al (2011) Effect of screening on ovarian cancer mortality. JAMA 305:2295–2303
Cancer Fact and Figures (2016) www.cancer.org/acs/ groups/content/@research/documents/document/ acspc-047079.pdf
Carlson KJ (2016) Ovarian cancer screening. www uptodate 2016
Chen C, Berek JS (2016) Epithelial cancer of the ovary, fallopian tube, and peritoneum. Clinical features and diagnosis. www.UpToDate.com
Choi HJ, Lee JH, Kang S et al (2006) Contrast-enhanced CT for differentiation of ovarian metastasis from gastrointestinal tract cancer: stomach cancer versus colon cancer. AJR Am J Roentgenol 187:741–745
Choudhary S, Fasih N, McInnes M, Marginean C (2009) Imaging of ovarian teratomas: appearances and complications. J Med Imaging Radiat Oncol 53:480–488
Clarke-Pearson DL (2009) Screening for ovarian cancer. N Engl J Med 361:170–177
Coakley FV, Choi PH, Gougoutas CA et al (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499 Comerci JT, Jr Licciardi F, Bergh PA et al (1994) Mature cystic teratoma. A clinicopathological evaluation of 517 cases
and review of the literature. Obstet Gynecol 84:22–28 De Waal YR, Thomas CM, Oei AL, Sweep FC, Massuger
LF (2009) Secondary ovarian malignancies: frequency, origin, and characteristics. Int J Gynecol Cancer 19:1160–1165
Dilks P, Narayan P, Reznek R, Sahdev A, Rockall A (2010) Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass. Eur Radiol 20:2176–2183
Diop AD, Fontarensky M, Montoriol PF, Da Ines D (2014) CT imaging of peritoneal carcinomatosis and its mimics. Diagn Interv Imaging 95:861–872
Dos Santos L, Mok E, Iasonos A et al (2007) Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol 105:321–324
Dujardin MI, Sekhri P, Turnbull LW (2014) Struma ovarii: role of imaging? Insights Imaging 5:41–51
Ferrozzi F, Tognini G, Bova D et al (2000) Non-Hodgkin lymphomas of the ovaries: MR findings. J Comput Assist Tomogr 24:416–420
Forstner R, Hricak H, Azizi L et al (1995) Ovarian cancer recurrence: value of MR imaging. Radiology 196:715–720
Forstner R, Sala E, Kinkel K, Spencer JA (2010) ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol 20:2773–2780
Forstner R, Thomassin-Naggara I, Cunha TM, Kinkel K, Masselli G, Kubik-Huch R, Spencer JA, Rockall A (2016a) ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol [Epub ahead of print] PMID: 27921156
Forstner R, Meissnitzer M, Cunha TM (2016b) Update on imaging of ovarian cancer. Curr Radiol Rep 4:31 Genetic/Familial High-Risk Assessment: Breast and
Ovarian, Version 1.2016 multigene testing National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. http://www. nccn.org/professionals/physician_gls/f_guidelines. asp. Accessed on 27 Feb 2016
Gomes FV, Dias JL, Lucas R, Cunha TM (2015) Primary fallopian tube carcinoma: review of MR imaging findings. Insights Imaging 6:431–439
Ha HK, Baek SY, Kim SH et al (1995) Krukenberg’s tumors of the ovary: MR imaging features. AJR Am J Roentgenol 164:1435–1439
Heifetz SA, Cushing B, Giller R et al (1998) Immature teratomas in children: pathologic considerations. Am J Surg Pathol 22:1115–1124
Höhn AK, Einenekel J, Wittekind C, Horn LC (2014) Neue FIGO-Klassifikation des Ovarial-Tuben und primären Peritonealkarzinoms. Pathologe 35:322–326 Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I (2005) Coexisting ovarian malignancy in young women with
endometrial cancer. Obstet Gynecol 106:693–699 Horta M, Cunha TM (2015) Sex cord-stromal tumors
of the ovary: a comprehensive review and update for radiologists. DIR 21:277–286
Hricak H, Chen M, Coakley FV et al (2000) Complex adnexal masses: detection and characterization with MRI: multivariate analysis. Radiology 214:39–46
Hricak H, Reinhold C, Ascher SM (2004) Ovarian dysgerminomas. In: Hricak H, Reinhold C, Ascher SM (eds) Gynecology top 100 diagnoses. WB Saunders Company, Amirsys/Salt Lake City, pp 98–100
CT and MRI in Ovarian Carcinoma |
321 |
|
|
Iver VR, Lee SI (2010) MRI, CT and PET/CT for ovarian cancer detection and adnexal characterization. AJR 194:311–321
Javadi S, Ghaneshan DM, Quayyum A, Iyer RB, Bhosale P (2016) Ovarian cancer, the revised FIGO staging system, and the role of Imaging. AJR 206:1351–1360 Jayson GC, Kohn EC, Kitchener HC, Ledermann JA
(2014) Ovarian cancer. Lancet 384:1376–1388
Jung SE, Lee JM, Rha SE et al (2002) CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics 22:1305–1325
Kaijser J, Vandecaveye V, Deroose CM et al (2014) Imaging techniques for the pre-surgical diagnosis of adnexal tumours. Best Pract Res Clin Obstet Gynaecol 28:683–695
Kandukuri SR, Rao J (2015) FIGO 2013 staging system for ovarian cancer: what is new in comparison to the 1988 staging system. Curr Opin Obstet Gynecol 27:48–52
Kawakami S, Togashi K, Kimura I et al (1993) Primary malignant tumor of the fallopian tube: appearance at CT and MR imaging. Radiology 186:503–508
Kawamoto S, Urban BA, Fishman EK (1999) CT of epithelial ovarian tumors. Radiographics 19:S85–S102 Khasper A, Addley HC, Abourokbah N, Nougaret S et al
(2012) T2-hypointense adnexal lesions: an imaging algorithm. Radiographics 32:1047–1061
Kido A, Togashi K, Konishi I et al (1999) Dermoid cysts of the ovary with malignant transformation: MR appearance. AJR 172:445–449
Kim SH (2002) Granulosa cell tumor of the ovary: common findings and unusual appearances on CT and MR. J Comput Assist Tomogr 26:756–761
Kim SH, Kim WH, Park KL et al (1996) CT and MR findings of Krukenberg tumors: comparison with primary ovarian tumors. J Comput Assist Tomogr 20: 393–398
Kim TH, Lim MC, Kim SI, Seo SS et al (2016) Preoperative prediction of cardiophrenic lymph node metastasis in advanced ovarian cancer using CT. Ann Surg Oncol 23:1302–1308
Komatsu KI, Konishi I, Mandai M et al (1996) Adnexal masses: transvaginal US and gadolinium-enhanced MR imaging assessment of intratumoral structure. Radiology 198:109–115
Koonings PP, Campbell K, Mishell DR, Grimes DA (1989) Relative frequency of primary ovarian neoplasm: a 10-year review. Obstet Gynecol 74:921–926 Kosari F, Daneshbod Y, Parwaresch R, Krams M, Wacker HH (2005) Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am
J Surg Pathol 29:1512–1520
Kottarathil VD, Anthony MA, Nair IR, Pvithran K (2013) Recent advances in granulosa cell tumory ovary: a review. Indian J Surg Oncol 4:37–47
Kurman R, Shih LM (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer. Shifting the paradigm. Hum Pathol 42:918–931
Kurman RJ, Carcangiu ML, Herrington CS et al (2014) WHO classification of tumours of temale reproductive
organs. In: WHO classification of tumours, 4th edn. WHO Press, Lyon
Kwek JW, Iyer RB (2006) Recurrent ovarian cancer: spectrum of imaging findings. Am J Roentgenol AJR 187:99–104
Kyriazi S, Kaye SB, deSouza NM (2010) Imaging ovarian cancer and peritoneal metastases – current and emerging techniques. Nat Rev Clin Oncol 7:381–393
Lagoo AS, Robboy SJ (2006) Lymphoma of the female genital tract: current status. Int J Gynecol Pathol 25:1–21
Lalwani N, Shanbhogue AKP, Vikram R, Nagar A, Jagirdar J, Prasad S (2010) Current update on Borderline ovarian neoplasm. AJR 194:330–336
Lalwani N, Prassad SR, Vikram R, Shanboghue AK et al (2011) Histologic, molecular, and cytogenetic features of ovarian cancers: implication for diagnosis and treatment. Radiographics 31:625–646
Leake JF, Currie JL, Rosenshein NB (1992) Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 47:150–158
Lee SI, Catalano OA, Dehdashti F (2015) Evaluation of gynecologic cancer with MR imaging. 18F-FDG PET/ CT, and PET/MR imaging. J Nucl Med 56:436–443
Lee SJ, Bae JH, Lee AW, Tong SY, Park YG, Park JS (2009) Clinical characteristics of metastatic tumors to the ovaries. J Korean Med Sci 24:114–119
Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177:1053–1064
Levy AD, Shaw JC, Sobin LH (2009) Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics 29:347–373
Li W, Wang H, Wang J et al (2012) Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients. BMC Cancer 12:278–286
Lorraine C, Pelosof LC, Gerber DE (2010) Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 85:838–854
Low RN, Saleh F, Song SYT et al (1999) Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination: a longitudinal study. Radiology 211:519–528
Low RN, Chen SC, Barone R et al (2003) Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MRI. Radiology 228:157–165
Low RN, Duggan B, Barone RM et al (2005) Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 235:918–926
Low RN, Barone RM, Lucero J (2015) comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 22:1708–1715
Megibow AJ, Hulnik DH, Bosniak MA et al (1985) Ovarian metastases: computed tomographic appearances. Radiology 156:161–164
322 |
R. Forstner |
|
|
Michielsen K, Vergote I, de Beeck O et al (2014) Whole– body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 24:889–901
Mironov O, Ishill NM, Mironov S, Vargas HA et al (2011) Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. Radiology 258:776–784
Mitchell DG, Javitt MC, Glanc P et al (2013) ACR appropriateness criteria staging and follow-up of ovarian cancer. J Am Coll Radiol 10:822–827
Moyer VA (2012) Screening for ovarian cancer. US preventive service task force reaffirmation recommendation statement. Ann Intern Med 157:900–904
Neto N, Cunha TM (2015) Do hereditary syndrome- related gynecologic cancers have any specific features. Insights Imaging 6:545–552
Nougaret S, Addley HC, Colombo PE, Fujii S, Al Sharif SS, Tirumani SH, Jardon K, Sala E, Reinhold C (2012) Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 32:1775–1800 Onyiuke I, Kirby AB, McCarthy S (2013) Primary gynecologic lymphoma: imaging findings. AJR
201:W648–W655
Outwater EK, Wagner BJ, Mannion C et al (1998) Sex cord stromal and steroid cell tumors of the ovary. Radiographics 18:1523–1546
Ovarian Cancer Statistics. www.cancerresearch uk.org Ozols RF, Schwartz PE, Eifel PJ (2001) Ovarian can-
cer, fallopian tube carcinoma, and peritoneal carcinoma. In: De Vita Jr VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1597–1632
Patel CM, Sahdev A, Reznek RH (2011) CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging 11:123–139
Pennington KP, Wsisher EM (2012) Hereditary ovarian cancer: beyond usual aspects. Gynecol Oncol 124: 347–353
Pfanneberg C, Schwenzer NF, Bruecher BL (2013) State of the Art Bildgebung bei Peritonealkarzinose. Fortschr Röntgenstr 184:205–213
Quayyum A, Coakley FV, Westphalen AC et al (2005) Role of CT and MRI in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96:301–306
Queiroz MA, Kubik-Huch R, Hauser N, Freiwald-Chilla B et al (2015) PET/MRI and PET/CT in advanced gynecological tumors: initial experience and comparison. Eur Radiol 25:2222–2230
Rockall A (2014) Diffusion weighted MRI in ovarian cancer. Curr Opin Oncol 26:529–535
Runnebaum IB, Arnold N (2013) Genetik des Ovarialkarzinoms. Gynäkologe 46:553–559
Sala E, Rockall AG, Freeman SJ et al (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologists needs to know. Radiology 266:717–740
Schmidt S, Meuli RA, Achtari C, Prior JO (2015) Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI and 18F-FDGPET/CT. Clin Nucl Med 40:371–377
Seidman JD, Russell P, Kurman RJ (2002) Surface epithelial tumors of the ovary. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract. Springer, Berlin/ Heidelberg/New York, pp 791–904
Sohaib SAA, Sahdev A, Trappen V et al (2003) Characterization of adnexal lesions on MRI. AJR Am J Roentgenol 180:1297–1304
Spencer JA, Perren TJ (2010) Recent EORTC and MRCUK studies: implications for imaging ovarian cancer. Cancer Imaging 10:135–136
Stevens SK, Hricak H, Stern JL (1991) Ovarian lesions: detection and characterization with gadolinium- enhanced MRI at 1.5 T. Radiology 181:481–488
Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB et al (2014) A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol 34:455–461
Tanaka YU, Kurosaki Y, Nishida M et al (1994) Ovarian dysgerminoma: MR and CT appearance. J Comput Assist Tomogr 18:443–448
Tanaka YO, Tsunoda H, Kitagawa Y et al (2004) Functioning ovarian tumors: direct and indirect findings at MRI. Radiographics 24:S147–S166
Tanaka YO, Okada S, Yagi T, Satoh T, Oki A, Tsunoda H, Yoshikawa H (2010) MRI of endometriotic cysts in association with ovarian carcinoma. AJR 194:355–361 Tanaka Y, Okada S, Satoh T, Matsumoto K, Oki A et al (2016) Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed
analysis. Cancer Imaging 16:3
Tayfur M, Kocabas A, Kaygisiz A, Tiryaki S, Polat M, Cefle K (2007) Dysgerminoma arising in Swyer syndrome. Internet J Pathology 7:2
Thomassin-Naggara I, Daraï E, Cuenod CA et al (2008a) Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumours. J Magn Reson Imaging 28:111–1120 Thomassin-Naggara I, Bazot M, Daraï E et al (2008b) Epithelial ovarian tumours: value of dynamic contrast- enhanced MR imaging and correlation with tumour
angiogenesis. Radiology 248:148–159 Thomassin-Naggara I, Daraï E, Cuenod CA, Fournier L,
Toussaint C, Bazot M (2009) Contribution of diffusion- weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 19:1544–1552
Thomassin-Naggara I, Balvay D, Aubert E et al (2012) Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol 22:738–745
Thomassin-Naggara I, Aubert E, Rockall A et al (2013) Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 267: 432–443
CT and MRI in Ovarian Carcinoma |
323 |
|
|
Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H (2000) Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol 16:500–505
Togashi K (2003) Ovarian cancer: the role of US, CT and MRI. Eur Radiol 13(Suppl 4):L87–L104
Tsili AC, Tsampoulas C, Argyropoulou M et al (2008) Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses. Eur Radiol 18:1049–1057
Yamaoka T, Togashi K, Koyama T et al (2003) Immature teratoma of the ovary: correlation of MR imaging and pathologic findings. Eur Radiol 13:313–319
Young RH, Scully RE (2002a) Sex-cord-stromal, steroid cell, and other ovarian tumors. In: Kurman RJ
(ed) Blaustein’s pathology of the female genital tract, 5th edn. Springer, Berlin\Heidelberg\New York, pp 905–965
Young RH, Scully RE (2002b) Metastatic tumors of the ovary. In: Kurmann RJ (ed) Blausteins’s pathology of the female genital tract, 5th edn. Springer, Berlin\ Heidelberg\New York, pp 1063–1101
Zhao SH, Quiang JW, Zhang GF, Ma FH, Cai SQ, LiHM WL (2014a) Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. Eur Radiol 24:2292–2299
Zhao SH, Quiang JW, Zhang GF, Wang SJ, Qiu HJ, Wang L (2014b) MRI in differentiating ovarian borderline from benign mucinous cystadenoma: pathologic correlation. J Magn Reson Imaging 39:162–166